Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data

Shreekant Parasuraman, Jingbo Yu, Dilan Paranagama, Sulena Shrestha, Li Wang, Onur Baser, Robyn Scherber

Research output: Contribution to journalArticle

Abstract

Patients with polycythemia vera (PV) have a high incidence of thrombotic events (TEs), contributing to a greater mortality risk than the general population. The relationship between hematocrit (HCT) levels and TE occurrence among patients with PV from the Veterans Health Administration (VHA) was evaluated to replicate findings of the CYTO-PV trial with a real-world patient population. This retrospective study used VHA medical record and claims data from the first claim with a PV diagnosis (index) until death, disenrollment, or end of study, collected between October 1, 2005, and September 30, 2012. Patients were aged ≥ 18 years at index, had ≥ 2 claims for PV (ICD-9-CM code, 238.4) ≥ 30 days apart during the identification period, continuous health plan enrollment from 12 months pre-index until end of study, and ≥ 3 HCT measurements per year during follow-up. This analysis focused on patients with no pre-index TE, and with all HCT values either < 45% or ≥ 45% during the follow-up period. The difference in TE risk between HCT groups was assessed using unadjusted Cox regression models based on time to first TE. Patients (N = 213) were mean (SD) age 68.9 (11.5) years, 98.6% male, and 61.5% white. TE rates for patients with HCT values < 45% versus ≥ 45% were 40.3% and 54.2%, respectively. Among patients with ≥ 1 HCT before TE, TE risk hazard ratio was 1.61 (95% CI, 1.03–2.51; P = 0.036). This analysis of the VHA population further supports effective monitoring and control of HCT levels < 45% to reduce TE risk in patients with PV.

Original languageEnglish (US)
Pages (from-to)2533-2539
Number of pages7
JournalAnnals of Hematology
Volume98
Issue number11
DOIs
StatePublished - Nov 1 2019

Keywords

  • Hematocrit
  • Polycythemia vera
  • Retrospective study
  • Thromboembolism
  • Thrombosis
  • Thrombotic event

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data'. Together they form a unique fingerprint.

  • Cite this